Key result
A single mutation in the coxsackievirus B3 capsid protein (VP1-F106L) increased replication speed via quicker genome release but reduced capsid stability, replication, and pathogenesis in mice.
Why the study?
It was unknown whether mutations could increase the replication speed of a virus already well adapted to replication in cultured cells.
Selecting for early viral progeny reveals a tradeoff between replication speed and overall fitness/pathogenesis in coxsackievirus B3.
Reveals replication-fitness tradeoffs in CVB3; hypothesis-generating for enterovirus attenuation before human translation.
RNA viruses exist as genetically heterogeneous populations due to high mutation rates, and many of these mutations reduce fitness and/or replication speed. However, it is unknown whether mutations can increase replication speed of a virus already well adapted to replication in cultured cells. By sequentially passaging coxsackievirus B3 in cultured cells and collecting the very earliest progeny, we selected for increased replication speed. We found that a single mutation in a viral capsid protein, VP1-F106L, was sufficient for the fast-replication phenotype. Characterization of this mutant revealed quicker genome release during entry compared to wild-type virus, highlighting a previously unappreciated infection barrier. However, this mutation also reduced capsid stability in vitro and reduced replication and pathogenesis in mice. These results reveal a tradeoff between overall replication speed and fitness. Importantly, this approach-selecting for the earliest viral progeny-could be applied to a variety of viral systems and has the potential to reveal unanticipated inefficiencies in viral replication cycles.
No takes yet. Share an insight, caveat, or question.
Lanahan et al. (2021) studied Coxsackievirus B3 infection. VP1-F106L mutation vs. Wild-type virus was evaluated on Replication speed and fitness. A single mutation in the coxsackievirus B3 capsid protein (VP1-F106L) increased replication speed via quicker genome release but reduced capsid stability, replication, and pathogenesis in mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: